Jacob M Estes - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jacob M Estes

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Gynecologic Oncology|February 17, 2007

Efficacy of anti-death receptor 5 (DR5) antibody (TRA-8) against primary human ovarian carcinoma using a novel ex vivo tissue slice modelJacob M Estes, Patsy G Oliver, J Michael Straughn, et al.

Obstetrics and Gynecology|May 2, 2008

Lynch syndrome in women less than 50 years of age with endometrial cancerKellie S Matthews, Jacob M Estes, Michael G Conner, et al.

Molecular Cancer Research : MCR|March 11, 2018

Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian CarcinomaRebecca C Arend, Angelina I Londoño, Allison M Montgomery, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Gynecologic Oncology|February 17, 2007

Efficacy of anti-death receptor 5 (DR5) antibody (TRA-8) against primary human ovarian carcinoma using a novel ex vivo tissue slice modelJacob M Estes, Patsy G Oliver, J Michael Straughn, et al.

Obstetrics and Gynecology|May 2, 2008

Lynch syndrome in women less than 50 years of age with endometrial cancerKellie S Matthews, Jacob M Estes, Michael G Conner, et al.

Molecular Cancer Research : MCR|March 11, 2018

Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian CarcinomaRebecca C Arend, Angelina I Londoño, Allison M Montgomery, et al.

Pageof 3